Search Results

Filter
  • 1-10 of  897 results for ""Osteoclasts""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Increased bone mass but delayed mineralization: in vivo and in vitro study for zoledronate in bone regeneration.

  • Authors : Wang R; Fujian Key Laboratory of Oral Diseases, School and Hospital of Stomatology, Fujian Medical University, Fujian, China.; Liu C

Subjects: Zoledronic Acid*/Zoledronic Acid*/Zoledronic Acid*/pharmacology ; Rats, Sprague-Dawley* ; Bone Regeneration*/Bone Regeneration*/Bone Regeneration*/drug effects

  • Source: BMC oral health [BMC Oral Health] 2024 Sep 27; Vol. 24 (1), pp. 1146. Date of Electronic Publication: 2024 Sep 27.Publisher: BioMed Central Country of Publication: England NLM ID: 101088684 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6831

Record details

×
Academic Journal

Effect of nitrogen-containing bisphosphonates on osteoclasts and osteoclastogenesis: an ultrastructural study.

  • Authors : Takagi Y; Department of Oral Anatomy and Developmental Biology, Showa University School of Dentistry, Tokyo 4142-8555, Japan.; Inoue S

Subjects: Alendronate/Alendronate/Alendronate/*pharmacology ; Apoptosis/Apoptosis/Apoptosis/*drug effects ; Diphosphonates/Diphosphonates/Diphosphonates/*pharmacology

  • Source: Microscopy (Oxford, England) [Microscopy (Oxf)] 2021 Jun 06; Vol. 70 (3), pp. 302-307.Publisher: Oxford University Press Country of Publication: England NLM ID: 101595834 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Minodronic acid induces morphological changes in osteoclasts at bone resorption sites and reaches a level required for antagonism of purinergic P2X2/3 receptors.

  • Authors : Tanaka M; Research Promotion, Ono Pharmaceutical Co., Ltd., 3-1-1 Sakurai, Shimamoto, Osaka, 618-8585, Japan. .; Hosoya A

Subjects: Bone Resorption/Bone Resorption/Bone Resorption/*drug therapy ; Bone Resorption/Bone Resorption/Bone Resorption/*pathology ; Diphosphonates/Diphosphonates/Diphosphonates/*therapeutic use

  • Source: Journal of bone and mineral metabolism [J Bone Miner Metab] 2018 Jan; Vol. 36 (1), pp. 54-63. Date of Electronic Publication: 2017 Feb 27.Publisher: Japanese Society of Bone and Mineral Metabolism Country of Publication: Japan NLM ID: 9436705 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Zoledronate suppressed angiogenesis and osteogenesis by inhibiting osteoclasts formation and secretion of PDGF-BB.

  • Authors : Gao SY; Department of Oral and Maxillofacial Surgery, Guanghua School of Stomatology, Guangdong Provincial Key Laboratory, Sun Yat-Sen University, Guangzhou, China.; Zheng GS

Subjects: Diphosphonates/Diphosphonates/Diphosphonates/*pharmacology ; Imidazoles/Imidazoles/Imidazoles/*pharmacology ; Neovascularization, Physiologic/Neovascularization, Physiologic/Neovascularization, Physiologic/*drug effects

  • Source: PloS one [PLoS One] 2017 Jun 08; Vol. 12 (6), pp. e0179248. Date of Electronic Publication: 2017 Jun 08 (Print Publication: 2017).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Pharmacologically Inactive Bisphosphonates as an Alternative Strategy for Targeting Osteoclasts: In Vivo Assessment of 5-Fluorodeoxyuridine-Alendronate in a Preclinical Model of Breast Cancer Bone Metastases.

  • Authors : Schem C; Department of Gynecology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.; Tower RJ

Subjects: Xenograft Model Antitumor Assays*; Alendronate/Alendronate/Alendronate/*analogs & derivatives ; Bone Neoplasms/Bone Neoplasms/Bone Neoplasms/*secondary

  • Source: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research [J Bone Miner Res] 2017 Mar; Vol. 32 (3), pp. 536-548. Date of Publisher: American Society for Bone and Mineral Research Country of Publication: United States NLM ID: 8610640 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Biological effects of aromatic bis[aminomethylidenebis(phosphonic)] acids in osteoclast precursors in vitro.

  • Authors : Nasulewicz-Goldeman A; Department of Experimental Oncology, Hirszfeld Institute of Immunology and Experimental Therapy, Wrocław, Poland.; Goldeman W

Subjects: Diphosphonates*/Diphosphonates*/Diphosphonates*/chemical synthesis ; Diphosphonates*/Diphosphonates*/Diphosphonates*/chemistry ; Diphosphonates*/Diphosphonates*/Diphosphonates*/pharmacology

  • Source: Chemical biology & drug design [Chem Biol Drug Des] 2019 Oct; Vol. 94 (4), pp. 1835-1848. Date of Electronic Publication: 2019 Aug 28.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101262549 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Bisphosphonate-enoxacin inhibit osteoclast formation and function by abrogating RANKL-induced JNK signalling pathways during osteoporosis treatment.

  • Authors : Xu Q; Department of Orthopedics, The First Affiliated Hospital of Nanchang University, Artificial Joints Engineering and Technology Research Center of Jiangxi Province, Nanchang, China.; Zhan P

Subjects: Diphosphonates/Diphosphonates/Diphosphonates/*pharmacology ; Enoxacin/Enoxacin/Enoxacin/*pharmacology ; MAP Kinase Signaling System/MAP Kinase Signaling System/MAP Kinase Signaling System/*drug effects

  • Source: Journal of cellular and molecular medicine [J Cell Mol Med] 2021 Nov; Vol. 25 (21), pp. 10126-10139. Date of Electronic Publication: 2021 Oct 15.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101083777 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Long-term therapy with intravenous zoledronate increases the number of nonattached osteoclasts.

  • Authors : Nagata MJH; University Estadual Paulista - UNESP, Dental School of Araçatuba, Department of Surgery and Integrated Clinic, Araçatuba, SP, Brazil. Electronic address: .; Messora MR

Subjects: Tooth Extraction*; Bone Density Conservation Agents/Bone Density Conservation Agents/Bone Density Conservation Agents/*administration & dosage ; Diphosphonates/Diphosphonates/Diphosphonates/*administration & dosage

  • Source: Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery [J Craniomaxillofac Surg] 2017 Nov; Vol. 45 (11), pp. Publisher: Elsevier Country of Publication: Scotland NLM ID: 8704309 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-4119

Record details

×
Academic Journal

Bisphosphonate-functionalized hyaluronic acid showing selective affinity for osteoclasts as a potential treatment for osteoporosis.

  • Authors : Kootala S; Department of Chemistry, A Science for Life Laboratory, Polymer Chemistry Division, Uppsala University, Po Box 538, Lägerhyddsvägen 1, Uppsala SE 75121, Sweden. .; Ossipov D

Subjects: Biocompatible Materials/Biocompatible Materials/Biocompatible Materials/*chemistry ; Bone Density Conservation Agents/Bone Density Conservation Agents/Bone Density Conservation Agents/*pharmacology ; Bone Resorption/Bone Resorption/Bone Resorption/*metabolism

  • Source: Biomaterials science [Biomater Sci] 2015 Aug; Vol. 3 (8), pp. 1197-207. Date of Electronic Publication: 2015 Jun 24.Publisher: Royal Society of Chemistry Country of Publication: England NLM ID: 101593571 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Aromatic Bis[aminomethylidenebis(phosphonic)] Acids Prevent Ovariectomy-Induced Bone Loss and Suppress Osteoclastogenesis in Mice.

  • Authors : Nasulewicz-Goldeman A; Department of Experimental Oncology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland.; Goldeman W

Subjects: Cancellous Bone*/Cancellous Bone*/Cancellous Bone*/metabolism ; Cancellous Bone*/Cancellous Bone*/Cancellous Bone*/pathology ; Osteoporosis, Postmenopausal*/Osteoporosis, Postmenopausal*/Osteoporosis, Postmenopausal*/drug therapy

  • Source: International journal of molecular sciences [Int J Mol Sci] 2021 Sep 03; Vol. 22 (17). Date of Electronic Publication: 2021 Sep 03.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
  • 1-10 of  897 results for ""Osteoclasts""